Chronic inflammatory demyelinating polyneuropathy (CIDP) may have resulted in changes to her daily routine, but Jamilah continues to find joy in her hobbies. Jamilah provides a glimpse into her diagnosis journey and shares advice for others living with CIDP.

#TogetherWeDiscover

Co-creation is key to our work to support the rare disease community. CEO Tim Van Hauwermeiren shares how relationships with disease biology experts and patients drive this work.

Learn more about how we deliver immunology solutions to the patient community.

#TogetherWeDiscover

This week at @AANMember Annual Meeting, we shared a breadth of immunology insights, including data from the Phase 3 ADHERE trial.

#TogetherWeDiscover #AANAM

The symptoms of chronic inflammatory demyelinating polyneuropathy (CIDP) often make completing daily activities more challenging. Jamilah shares her personal experience living with CIDP to increase awareness of this rare autoimmune disease.

#TogetherWeDiscover

Through our Immunology Innovation Program, we leverage our antibody engineering expertise with our academic and industry collaborators’ biology insights to co-create new potential treatment candidates.

#TogetherWeDiscover

Anaya’s journey with myasthenia gravis (MG) began when she was just 12 years old. In her episode of Untold Stories, Anaya reflects on how she learned to adapt to her physical limitations and advocate for herself as a young Black woman.

#TogetherWeDiscover

In 2023, argenx advanced our mission to transform the treatment of autoimmune diseases and deliver novel therapies to patients. Our 2023 Annual Report is live.

We look forward to strengthening and expanding collaborations driving this innovation in 2024.

#TogetherWeDiscover

In honor of Autoimmune Disease Awareness Month, we remain committed to expanding awareness and recognizing the many people affected by autoimmune diseases.

Learn more about our dedication to this community.

#TogetherWeDiscover #argenx

Our ESG practices drive the culture of innovation at argenx, allowing us to expand understanding of autoimmune diseases and bring differentiated treatments to patients worldwide.

Discover some of the patient stories inspiring our work in our 2023 ESG Report.

#TogetherWeDiscover

Today argenx announced a pivotal advancement in our work to develop innovative treatments for rare autoimmune diseases. This is our first global approval for primary immune thrombocytopenia (ITP) and will greatly impact the lives of patients in Japan.

#TogetherWeDiscover

At argenx, our argonauts are empowered to make a difference. Hear how Pallavi Jain, Medical Science Liaison, draws on insights from her scientific background in the field.

Learn more about opportunities at argenx.

#TogetherWeDiscover #BiotechCareers

Earlier this month, our team attended #MDA2024 , where we shared our latest pipeline advancements and connected with immunology experts. We’re inspired by all the progress still ahead.

Discover more about our immunology solutions.

#TogetherWeDiscover #argenx

Collaboration is key to ensuring patient access to treatment. Emily Mayer, Field Reimbursement Manager, shares how she is motivated by working through challenges with her team.

Discover open roles on our careers page.

#TogetherWeDiscover #BiotechCareers

It’s International Women’s Day! Today and every day, our female argonauts #InspireInclusion through their work. Hear their empowering words of wisdom and advice to other women interested in careers in biotech.

#WomenInBiotech

Today argenx announced that eight abstracts featuring clinical trial and real-world data in rare, neurologic autoimmune diseases will be presented at the @AANMember American Academy of Neurology (AAN) Annual Meeting in April.

#TogetherWeDiscover #AANAM

argenx is proud to support All United for MG and their movement for myasthenia gravis (MG) awareness!

Let’s unite to make a difference. #AllUnitedForMG

Our #argenx U.S. commercial team came together in February for a great week of collaboration, workshops, and networking.

Discover opportunities to join our team!

#TogetherWeDiscover

Our argonauts are “sharing their colors” and illuminating our Ghent office in support of #RareDiseaseDay . Join us in this global effort to #ShareYourColors , raise awareness and recognize the community of over 300 million patients living with a rare disease.

#TogetherWeDiscover

In honor of Rare Disease Day, we are a proud sponsor of this year’s Rare Artist Gallery as part of Rare Disease Week on Capitol Hill. Swipe to get a closer look at this year’s events!

#RareDisease Day #RareArtistGallery #RareDisease #argenx

In 2023, we saw advancements in multiple pipeline-in-a-product candidates and continued investment in our Immunology Innovation Program (IIP) to drive future progress. Our full year and 2023 Q4 earnings are now available.

#TogetherWeDiscover #argenx